How to Obtain a Solid Track Record in Medicinal Chemistry Research Services Bruno Giethlen, Chief Scientific Officer, Prestwick Chemicals speaking at Pharma Outsourcing Congress 2011
Biomarkers of Metabolic Syndrome in Clinical Trials This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Smarter Regulation: the Key to Radical Transformation of the Pharmaceutical Industry Joyce Tait, Professor, University of Edinburgh, speaking at the Pharma Outsourcing Congress 2010.
Legal Aspects of Outsourcing Drug Discovery Hiroshi Sheraton, Partner, McDermott Will & Emery UK, speaking at the Pharma Outsourcing Congress 2010.
A Quality Assurance Perspective on Selecting and Monitoring Contract Research Organizations (CROs) Thomas Ott, Pharmaceutical Consultant, speaking at the Pharma Outsourcing Congress 2010.
Education and Training in Clinical Research: What are the Best Outsourcing Strategies? Heinrich Klech, Professor/CEO, Vienna School of Clinical Research, speaking at the Pharma Outsourcing Congress 2010.
Assessing the Security Practices of Partners Peter Hesse, President, Gemini Security Solutions, Inc, speaking at the Pharma Outsourcing Congress 2010.
Outsourcing in Pharma R&D, Gambling or Added Value? Michael Becker, Head of Marketing and Communication, Solvias AG, speaking at Pharma Outsourcing Congress 2010
MAPK Inhibitors: New Chemotherapeutic Opportunities for the ‘Ageing’ Disease Mark Bagley, Reader in Organic Chemistry, Cardiff University, speaking at MedChem Europe 2009